Good Life Advisors LLC cut its stake in shares of BrainsWay Ltd. (NASDAQ:BWAY – Free Report) by 50.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,900 shares of the company’s stock after selling 27,900 shares during the period. Good Life Advisors LLC’s holdings in BrainsWay were worth $263,000 at the end of the most recent reporting period.
Separately, JPMorgan Chase & Co. lifted its stake in BrainsWay by 316.3% in the third quarter. JPMorgan Chase & Co. now owns 14,769 shares of the company’s stock valued at $136,000 after acquiring an additional 11,221 shares during the last quarter. 30.11% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reiterated a “buy” rating and issued a $16.00 target price on shares of BrainsWay in a research note on Monday, December 23rd.
BrainsWay Price Performance
NASDAQ:BWAY opened at $10.75 on Friday. The stock has a market cap of $202.32 million, a P/E ratio of 107.51 and a beta of 1.25. BrainsWay Ltd. has a one year low of $4.61 and a one year high of $11.79. The company has a fifty day moving average price of $10.13 and a 200 day moving average price of $9.35.
BrainsWay Company Profile
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.
Recommended Stories
- Five stocks we like better than BrainsWay
- Differences Between Momentum Investing and Long Term Investing
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Stock Splits, Do They Really Impact Investors?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What Are Dividend Contenders? Investing in Dividend Contenders
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding BWAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BrainsWay Ltd. (NASDAQ:BWAY – Free Report).
Receive News & Ratings for BrainsWay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrainsWay and related companies with MarketBeat.com's FREE daily email newsletter.
